INFOGRAPHIC: 2-year efficacy, durability and safety of intravitreal faricimab with treat-and-extend dosing up to 16 weeks in diabetic macular oedema (pooled results from YOSEMITE and RHINE).

Wijesingha, Naomi; Gibson, Kara; Willis, Jeffrey R; Sivaprasad, Sobha

Wijesingha, Naomi; Gibson, Kara; Willis, Jeffrey R; Sivaprasad, Sobha.

Afiliación

Wijesingha N; UCL Institute of Ophthalmology, London, UK.
Gibson K; Moorfields Eye Hospital NHS Foundation Trust, London, UK.
Willis JR; Roche Products Ltd., Welwyn Garden City, UK.
Sivaprasad S; Genentech Inc., South San Francisco, CA, USA.

Eye (Lond) ; 2024 Jul 29.

Article en En | MEDLINE | ID: mdl-39075261

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Eye (Lond) Asunto de la revista: OFTALMOLOGIA Año: 2024 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Eye (Lond) Asunto de la revista: OFTALMOLOGIA Año: 2024 Tipo del documento: Article